Get the Stockscreener App
31.26
0.06%
-0.02
Pre-market:
31.17
-0.09
-0.29%
Catalyst Pharmaceuticals Inc Stock (CPRX) Forecast
The Catalyst Pharmaceuticals Inc (CPRX) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $34.18, representing a +9.33% increase from the current price of $31.26. The highest analyst price target is $34.66, and the lowest is $33.69.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month CPRX Price Target
Average 38.86
(+24.31% Upside)
Is Catalyst Pharmaceuticals Inc (CPRX) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 73.38 | Sell |
| STOCH(9,6) | 85.13 | Sell |
| STOCHRSI(14) | 70.71 | Neutral |
| MACD(12,26) | 1.2436 | Sell |
| ADX(14) | 56.86 | Buy |
| William %R | -3.8314 | Sell |
| CCI(14) | 8.6715 | Neutral |
Buy: 1
Sell: 4
Neutral: 2
Summary: Sell
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
31.20
Buy
|
31.01
Buy
|
| MA20 |
30.42
Buy
|
30.16
Buy
|
| MA50 |
27.00
Buy
|
28.01
Buy
|
| MA100 |
25.46
Buy
|
26.21
Buy
|
| MA200 |
23.44
Buy
|
24.76
Buy
|
Buy: 10
Sell: 0
Neutral: 0
Summary: Buy
According to our latest analysis, CPRX could be considered a Strong Buy, with 17 technical analysis indicators signaling 11 Buy signals, 4 signaling Sell signals and 2 Neutral signals. This might be a good time to open fresh positions on CPRX, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 73.38 indicates that CPRX is overbought. This suggests that CPRX price has experienced a significant increase over a specified lookback period, potentially leading to a correction.
- STOCH (Stochastic Oscillator): The STOCH value of 85.13 indicates that CPRX is oversold. This means that CPRX price is at or near the highest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 70.71 indicates that CPRX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 56.86 suggests an extremely strong trend in the market. Such high values are relatively rare and indicate a very robust directional movement.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 8.6715 indicates that CPRX is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term CPRX price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Catalyst Pharmaceuticals Inc financial reports and earnings history, Catalyst Pharmaceuticals Inc (CPRX) stock could reach $29.75 by 2030, $165.85 by 2040 and $201.73 by 2050. See the projected annual prices until 2050 of the Catalyst Pharmaceuticals Inc stock below:
- Catalyst Pharmaceuticals Inc (CPRX) is expected to reach an average price of $123.72 in 2035, with a high prediction of $123.75 and a low estimate of $120.27. This indicates an $295.78% rise from the last recorded price of $31.26.
- Catalyst Pharmaceuticals Inc (CPRX) stock is projected to chart a bullish course in 2040, with an average price target of $164.03, representing an $424.72% surge from its current level. The forecast ranges from a conservative $162.98 to a sky-high $165.85.
- Our analysts predict Catalyst Pharmaceuticals Inc (CPRX) to jump 503.08% by 2045, soaring from $186.66 to an average price of $188.52, potentially reaching $191.56. While $186.66 is the low estimate, the potential upside is significant.
- Catalyst Pharmaceuticals Inc (CPRX) stock is expected to climb by 2050, reaching an average of $201.45, a $544.45% jump from its current level. However, a wide range of estimates exists, with high and low targets of $201.73 and $199.19, respectively, highlighting the market's uncertainty.
Catalyst Pharmaceuticals Inc Stock (CPRX) Year by Year Forecast
Catalyst Pharmaceuticals Inc Stock (CPRX) Price Forecast for 2026
The predicted value for Catalyst Pharmaceuticals Inc (CPRX) in 2026 is set at an average of $34.46. Estimates vary from a peak of $39.97 to a trough of $28.95, indicating an +10.24% surge from the present price of $31.26.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| June, 2026 | $34.26 | $33.69 | $34.66 | +9.60% |
| July, 2026 | $36.24 | $34.30 | $36.27 | +15.95% |
| August, 2026 | $37.12 | $36.32 | $37.26 | +18.74% |
| September, 2026 | $37.77 | $37.15 | $38.08 | +20.83% |
| October, 2026 | $38.63 | $37.63 | $38.86 | +23.59% |
| November, 2026 | $38.98 | $38.54 | $39.22 | +24.68% |
| December, 2026 | $39.57 | $38.73 | $39.97 | +26.58% |
Catalyst Pharmaceuticals Inc Stock (CPRX) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Catalyst Pharmaceuticals Inc (CPRX) is $48.21, with a high forecast of $56.93 and a low forecast of $39.48. This indicates an +54.21% increase from the last price of $31.26.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $40.67 | $39.48 | $41.19 | +30.11% |
| February, 2027 | $42.87 | $40.74 | $43.06 | +37.15% |
| March, 2027 | $43.26 | $42.69 | $43.55 | +38.38% |
| April, 2027 | $43.24 | $42.97 | $44.03 | +38.32% |
| May, 2027 | $43.27 | $42.49 | $43.49 | +38.43% |
| June, 2027 | $46.08 | $43.41 | $46.75 | +47.39% |
| July, 2027 | $47.38 | $45.88 | $47.73 | +51.56% |
| August, 2027 | $47.78 | $47.37 | $48.28 | +52.85% |
| September, 2027 | $47.86 | $46.51 | $48.14 | +53.12% |
| October, 2027 | $47.63 | $47.33 | $48.43 | +52.36% |
| November, 2027 | $49.38 | $47.72 | $49.57 | +57.96% |
| December, 2027 | $56.52 | $49.34 | $56.93 | +80.81% |
Catalyst Pharmaceuticals Inc Stock (CPRX) Price Forecast for 2028
In 2028, Catalyst Pharmaceuticals Inc (CPRX) is projected to reach an average price of $62.08, with a high projection of $68.75 and a low estimate of $55.42. This indicates an +98.60% rise from the last price of $31.26.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $57.01 | $55.95 | $58.01 | +82.39% |
| February, 2028 | $56.74 | $55.42 | $60.81 | +81.50% |
| March, 2028 | $58.58 | $56.23 | $59.26 | +87.40% |
| April, 2028 | $62.32 | $58.22 | $63.11 | +99.37% |
| May, 2028 | $65.17 | $61.46 | $65.94 | +108.47% |
| June, 2028 | $67.60 | $64.26 | $68.75 | +116.25% |
| July, 2028 | $62.91 | $60.26 | $65.37 | +101.25% |
| August, 2028 | $62.88 | $62.60 | $63.71 | +101.17% |
| September, 2028 | $66.27 | $62.28 | $66.30 | +111.99% |
| October, 2028 | $66.74 | $64.91 | $67.43 | +113.50% |
| November, 2028 | $61.88 | $61.36 | $67.46 | +97.96% |
| December, 2028 | $64.42 | $61.90 | $64.76 | +106.06% |
Catalyst Pharmaceuticals Inc Stock (CPRX) Price Forecast for 2029
The 2029 price forecast for Catalyst Pharmaceuticals Inc Stock (CPRX) is $50.95 on average, with a high prediction of $75.47 and a low estimate of $26.43. This represents an +63.00% increase from the previous price of $31.26.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $65.61 | $63.32 | $65.86 | +109.88% |
| February, 2029 | $66.66 | $65.37 | $67.69 | +113.25% |
| March, 2029 | $65.52 | $65.40 | $67.10 | +109.61% |
| April, 2029 | $66.49 | $64.98 | $67.12 | +112.69% |
| May, 2029 | $67.36 | $65.99 | $67.95 | +115.48% |
| June, 2029 | $69.97 | $67.10 | $70.00 | +123.84% |
| July, 2029 | $72.60 | $68.47 | $73.19 | +132.26% |
| August, 2029 | $71.00 | $70.34 | $73.15 | +127.12% |
| September, 2029 | $71.28 | $70.04 | $71.59 | +128.03% |
| October, 2029 | $73.77 | $71.32 | $75.47 | +136.00% |
| November, 2029 | $73.82 | $73.34 | $74.94 | +136.14% |
| December, 2029 | $27.30 | $26.43 | $74.69 | -12.67% |
Catalyst Pharmaceuticals Inc Stock (CPRX) Price Forecast for 2030
Catalyst Pharmaceuticals Inc Stock (CPRX) is expected to reach an average price of $36.10 in 2030, with a high forecast of $44.70 and a low forecast of $27.50. This signifies an +15.48% surge from the last price of $31.26.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $29.61 | $27.50 | $29.75 | -5.29% |
| February, 2030 | $31.17 | $29.63 | $31.34 | -0.28% |
| March, 2030 | $33.43 | $31.43 | $33.56 | +6.93% |
| April, 2030 | $35.78 | $33.32 | $35.96 | +14.47% |
| May, 2030 | $36.58 | $35.88 | $37.94 | +17.01% |
| June, 2030 | $38.15 | $36.32 | $38.21 | +22.05% |
| July, 2030 | $38.61 | $37.46 | $39.10 | +23.53% |
| August, 2030 | $39.25 | $38.76 | $39.97 | +25.54% |
| September, 2030 | $41.10 | $39.47 | $41.36 | +31.48% |
| October, 2030 | $43.13 | $41.17 | $43.27 | +37.98% |
| November, 2030 | $42.78 | $42.17 | $44.10 | +36.84% |
| December, 2030 | $44.42 | $42.50 | $44.70 | +42.09% |
2.98%
1.33%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):